MEGHAN FROST: Open Payments
NPI 1093289498 · GIBSONIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 20 payments from 8 companies in 2025. Trend: 2023 $181 · 2024 $636 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $354 |
| Novo Nordisk Inc | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| PFIZER INC. | 2 | $43 |
| Tandem Diabetes Care, Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: QULIPTA, UBRELVY, PREVNAR 20, t:slim X2 Insulin Pump with Control-IQ, TRELEGY ELLIPTA, SHINGRIX, AIRSUPRA, VOQUEZNA.
Industry payments across PA — which companies pay providers there.
